Arkolith/Insider Trading/OYST/Form 4

Ozawa Clare

Director, 10% OwnerOyster Point Pharma, Inc. (OYST) · full profile →Form 4 · filed Jan 7, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2022Other(J)120—$011K
Jan 5, 2022Other(J)52K—$00
Jan 5, 2022Other(J)52K—$052K
Jan 5, 2022Other(J)200K—$0415K
Jan 5, 2022Other(J)1K—$02K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-001359) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML